alobresib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for alobresib, covering 2020-12-29 to 2020-12-29. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alobresib (Formerly GS-5829) in Adults With Advanced Solid Tumors and Lymphomas and in Combination With Exemestane or Fulvestrant in Adults With Estrogen Receptor Positive Breast Cancer [Phase 1]